All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BalstilimabAGEN2034Phase 23 trials

    ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer

  • BoserolimabMK-5890Phase 23 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Cancer

  • BrogidirsenNS-089, NCNP-02Phase 23 trials

    NS Pharma, Inc. · Duchenne Muscular Dystrophy, Exon 44, DMD

  • BT5528nuzefatide pevedotinPhase 23 trials

    BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer

  • BudoprutugTNT119Phase 23 trials

    Climb Bio, Inc. · Primary Membranous Nephropathy, Systemic Lupus Erthematosus, Immune Thrombocytopenia (ITP)

  • CBP-0276Phase 23 trials

    Clarent Biopharma, Inc. · Psoriasis, Arthritic Psoriasis, Hip or Knee Replacement

  • CID-103Phase 23 trials

    CASI pharmaceuticals, Inc. · Chronic Immune Thrombocytopenia, Antibody Mediated Rejection

  • DDY391Phase 23 trials

    Novartis · Moderate to Severe Psoriatic Arthritis, Sjögren's Disease

  • Dihuang Baoyuan Granulesprescription BPhase 23 trials

    Beijing Supreme Life Pharmaceutical Technology Co., Ltd. · Diabetes Mellitus, Type 2, Diabetes, Type2diabetes

  • ENV-294Phase 23 trials

    Enveda Therapeutics · Atopic Dermatitis (AD), Atopic Dermatitis, Asthma

  • ENX-102ENX-102 -dose, ENX-102 mid-dosePhase 23 trials

    Engrail Therapeutics INC · General Anxiety Disorder, Social Anxiety Disorder (SAD), Generalized Anxiety Disorder

  • ESG206ESG206-2Phase 23 trials

    Shanghai Escugen Biotechnology Co., Ltd · Systemic Lupus Erythematosus (SLE), Immune Thrombocytopenia (ITP), Primary Sjögren Syndrome

  • ETX101Phase 23 trials

    Encoded Therapeutics · Dravet Syndrome

  • Fuling Yunhua Granulesprescription APhase 23 trials

    Beijing Supreme Life Pharmaceutical Technology Co., Ltd. · Diabetes Mellitus, Type 2, Diabetes, Type2diabetes

  • GalvokimigUCB9741Phase 23 trials

    UCB · Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis

  • GenSci048Phase 23 trials

    Changchun GeneScience Pharmaceutical Co., Ltd. · Uveitis, Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)

  • GIA632Phase 23 trials

    Novartis · Atopic Dermatitis, Non-segmental Vitiligo, Cutaneous Lichen Planus

  • GSK4532990Phase 23 trials

    GSK · Non-alcoholic Fatty Liver Disease, Liver Diseases, Alcoholic, Nonalcoholic Fatty Liver Disease

  • GV20-0251Phase 23 trials

    GV20 Therapeutics · Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma, pMMR/MSS Adenocarcinoma of the Colon or Rectum

  • HRS-2189Phase 23 trials

    Jiangsu HengRui Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer, Breast Cancer, Prostate Cancer

  • HRS-4508Phase 23 trials

    Jiangsu HengRui Medicine Co., Ltd. · Solid Tumor, Lung Cancer

  • HRS-4729Phase 23 trials

    Fujian Shengdi Pharmaceutical Co., Ltd. · Metabolic Dysfunction-Associated Steatohepatitis (MASH), Type 2 Diabetes, Overweight or Obesity

  • HRS-5346MK-7262Phase 23 trials

    Shandong Suncadia Medicine Co., Ltd. · Lipoprotein(a), Lipoprotein Disorder, Treatment of Lipoprotein Disorder

  • HS_SW01 cellsHS_SW01Phase 23 trials

    Shenzhen Huishan Biotechnology Co., Ltd. · Ankylosing Spondylitis, Primary Ovarian Insufficiency (Poi), Systemic Sclerosis (SSc)

  • HSK39297 200mgQDPhase 23 trials

    Haisco Pharmaceutical Group Co., Ltd. · IgA Nephropathy (IgAN), Lupus Nephritis (LN)

  • HT-101Phase 23 trials

    Suzhou HepaThera Biotech Co., Ltd. · Chronic Hepatitis B, Chronic Hepatitis B Virus Infection

  • HT-102Phase 23 trials

    Suzhou HepaThera Biotech Co., Ltd. · Chronic Hepatitis B, Chronic Hepatitis B Virus Infection

  • Human Dopaminergic Progenitor CellsNouvNeu001Phase 23 trials

    iRegene Therapeutics Co., Ltd. · Parkinson Disease, Parkinson Disease (PD)

  • IAP0971Phase 23 trials

    SUNHO(China)BioPharmaceutical CO., Ltd. · Advanced Malignant Neoplasm, Advanced or Metastatic Non-small Cell Lung Cancer, Bladder Cancer

  • IMG-007Phase 23 trials

    Inmagene LLC · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema

  • IMR-687Tovinontrine, CRD-750Phase 23 trials

    Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases

  • INCAGN02385Phase 23 trials

    Incyte · Melanoma, Endometrial Cancer, Head and Neck Cancer

  • INCAGN02390Phase 23 trials

    Incyte · Melanoma, Endometrial Cancer, Head and Neck Cancer

  • INE963Phase 23 trials

    Novartis · Uncomplicated Plasmodium Falciparum Malaria

  • IPG11406Phase 23 trials

    Nanjing Immunophage Biotech Co., Ltd · Lupus Nephritis, Moderately to Severely Active Ulcerative Colitis (UC)

  • iPSChuman allogeneic induced pluripotent stem cell -derived dopaminergic neural progenitor cell, Allogeneic Human Induced Pluripotent Stem Cell -Derived Motor Neuron Progenitor CellsPhase 23 trials

    XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · Spinal Cord Injury, Safety, Efficacy

  • JAB-23E73Phase 23 trials

    Jacobio Pharmaceuticals Co., Ltd. · Advanced Solid Tumor, Advanced Solid Tumors, Metastatic Pancreatic Ductal Adenocarcinoma

  • JDQ443OpnurasibPhase 23 trials

    Novartis · Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation, Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation

  • JPI-547Phase 23 trials

    Onconic Therapeutics Inc. · Pancreatic Ductal Adenocarcinoma, Gastric Cancer (GC), Ovarian Cancer

  • KT-621Phase 23 trials

    Kymera Therapeutics, Inc. · Eosinophilic Asthma, Atopic Dermatitis, Asthma (Diagnosis)

  • LT-002-158Phase 23 trials

    Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)

  • LT3001Phase 23 trials

    Lumosa Therapeutics Co., Ltd. · Acute Ischemic Stroke

  • Lu AG13909AsedebartPhase 23 trials

    H. Lundbeck A/S · Cushing's Disease, Congenital Adrenal Hyperplasia, Adrenal Hyperplasia, Congenital

  • LY4065967Phase 23 trials

    Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee

  • MacupatideLY3532226Phase 23 trials

    Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2

  • MAR001Phase 23 trials

    Marea Therapeutics · Hypertriglyceridemia

  • MCLA-129Phase 23 trials

    Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, Solid Tumor, Head and Neck Cancer

  • mesenchymal stem cellumbilical cord derived MSCsPhase 23 trials

    Cell Energy Life Sciences Group Co. LTD · AIDS, Ischemic Heart Disease, Osteoarthritis

  • MHB036CPhase 23 trials

    Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Breast Cancer, Advanced Malignant Solid Tumor, Advanced Lung Cancer

  • MK-0482Phase 23 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung

NewerPage 31 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.